Conditions: Healthy
Keywords: Bioequivalence Healthy Subjects
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 24
Healthy volunteers: yes

Brief summary:
The objective of this study was to compare the rate and extent of absorption of venlafaxine hydrochloride 150 mg extended-release capsules (test) versus Effexor® XR (reference) administered as 1 x 150 mg extended-release capsule under fasting conditions.

Detailed description:

Arms:
arm 1: 150 mg Venlafaxine Hydrochloride Extended-Release Capsules arm 2: 150 mg Effexor® XR Extended-Release Capsules

Interventions: intervention 1: Venlafaxine Hydrochloride intervention 2: Effexor® XR
Intervention descriptions: intervention 1: 150 mg Extended-Release Capsule intervention 2: 150 mg Extended-Release Capsule

Protocol document: